Moreover, high CD44 expression has been correlated to worse prognosis in HNSCC 11–14, and in a pilot study from the rural county of Dalarna, Sweden, we found that medium/strong CD44 intensity staining was a negative prognostic factor in tonsillar and base of tongue cancer 11. Here, CD44 is linked to head and neck squamous cell carcinoma.